ZaiLab-en-JPM 2026 Presentation_vFinal.pdf

1、 2026.Zai Lab.All Rights Reserved.NASDAQ:ZLAB|HKEX:9688Executing a Dual-Engine Growth Strategy44th Annual J.P.Morgan Healthcare Conference 2026Forward-Looking StatementsThis presentation contains forward-looking statements relating to our strategy and plans;potential of and expectations for our busi

2、ness,clinical development strategy,and pipeline programs;our goals and expectations under our growth strategy(including our expectations regarding our commercial-stage products,clinical-stage global-right products,revenue growth,profitability and timeline to profitability,operating margins,and cash

3、flow);the sales potential of our programs;capital allocation and investment strategy;clinical development programs and related clinical trials;expected timing and results of clinical trial data,data readouts,and presentations;risks and uncertainties associated with drug development,commercialization

4、 and outreach;regulatory discussions,submissions,filings,and approvals and the timing and scope thereof;the potential benefits,safety,and efficacy of our products and product candidates and those of our collaboration partners;the expected benefits and potential of investments,collaborations,and busi

5、ness development activities;the potential market opportunities of,and estimated addressable markets for,our drug candidates;our future financial and operating results;and financial guidance.All statements,other than statements of historical fact,included in this presentation are forward-looking stat

6、ements,and can be identified by words such as“aim,”“anticipate,”“believe,”“continue,”“could,”“estimate,”“expect,”“forecast,”“goal,”“intend,”“may,”“plan,”“possible,”“potential,”“target,”“will,”“would,”and other similar expressions.Such statements constitute forward-looking statements within the meani